Discontinued — last reported Q4 '23
Pharmaceutical — Total operating earnings
Cardinal Health Pharmaceutical — Total operating earnings increased by 2.2% to $518.00M in Q4 2023 compared to the prior quarter. Year-over-year, this metric grew by 11.6%, from $464.00M to $518.00M. Over 2 years (FY 2021 to FY 2023), Pharmaceutical — Total operating earnings shows an upward trend with a 9.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase reflects improved operational efficiency, better pricing power, or favorable product mix shifts.
Detailed definition
This represents the profitability of the pharmaceutical segment after deducting the cost of goods sold and operating exp...
Peer comparison
Standard performance metric for business segments across the healthcare distribution and logistics industry.
cah_segment_pharmaceutical_total_operating_earningsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $358.00M | $406.00M | $426.00M | $487.00M | $451.00M | $431.00M | $464.00M | $600.00M | $504.00M | $507.00M | $518.00M |
| QoQ Change | — | +13.4% | +4.9% | +14.3% | -7.4% | -4.4% | +7.7% | +29.3% | -16.0% | +0.6% | +2.2% |
| YoY Change | — | — | — | — | +26.0% | +6.2% | +8.9% | +23.2% | +11.8% | +17.6% | +11.6% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Cardinal Health's pharmaceutical — total operating earnings?
- Cardinal Health (CAH) reported pharmaceutical — total operating earnings of $518.00M in Q4 2023.
- How has Cardinal Health's pharmaceutical — total operating earnings changed year-over-year?
- Cardinal Health's pharmaceutical — total operating earnings increased by 11.6% year-over-year, from $464.00M to $518.00M.
- What is the long-term trend for Cardinal Health's pharmaceutical — total operating earnings?
- Over 2 years (2021 to 2023), Cardinal Health's pharmaceutical — total operating earnings has grown at a 9.0% compound annual growth rate (CAGR), from $1.68B to $2.00B.
- What does pharmaceutical — total operating earnings mean?
- The profit generated by the pharmaceutical segment from its core business operations before interest and taxes.